EXPANDING CAPACITY FOR RESEARCH DRIVEN CARE AND NURSING SCOPE AT AN NCI DESIGNATED COMPREHENSIVE CANCER CENTER.

Significance & Background: At an NCI-designated Comprehensive Cancer Center (CCC) serving over 64,000 patients annually, trial volume and complexity have outgrown the capacity of our 10-bed Clinical Trials Unit (CTU). The centralized model for investigational product (IP) administration has increasi...

Descripción completa

Detalles Bibliográficos
Publicado en:Oncology Nursing Forum Vol. 53; no. 2; p. 199
Autores principales: Stohr, Elizabeth, Marsolini, Trisha
Formato: Journal Article
Publicado: Oncology Nursing Society Mar2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194211456&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 194211456
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0190535X
        4F0
      jtl: Oncology Nursing Forum
      issn: 0190535X
      maglogo: N
    pubinfo:
      dt: Mar2026
      vid: 53
      iid: 2
      pid: 12496
      pub: Oncology Nursing Society
      place: Pittsburgh, Pennsylvania
    artinfo:
      ui:
        194211456
        10.1188/26.ONF.e26535271
        194211456
      ppf: 199
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: EXPANDING CAPACITY FOR RESEARCH DRIVEN CARE AND NURSING SCOPE AT AN NCI DESIGNATED COMPREHENSIVE CANCER CENTER.
      aug:
        au:
          Stohr, Elizabeth
          Marsolini, Trisha
        affil: MSN, RN, Fred Hutch Cancer Center, Seattle, WA
      sug:
      ab: Significance & Background: At an NCI-designated Comprehensive Cancer Center (CCC) serving over 64,000 patients annually, trial volume and complexity have outgrown the capacity of our 10-bed Clinical Trials Unit (CTU). The centralized model for investigational product (IP) administration has increasingly strained patient scheduling and siloed nursing skill development. A significant gap exists between frontline nursing operations and research integration. Purpose: To describe the establishment of a program to support IP administration across clinic operations, optimizing the role of nurses in in-novations of oncology research care delivery. Interventions: Initial meetings with a cross-disciplinary committee including research nurses, research managers, and nursing leadership who established operational criteria for implementing trials in Care Neighborhood (CN) infusion areas, where staffing ratios and experience differ from the CTU. Trials were selected from disease-specific portfolios based on these criteria and introduced in a phased approach, adding 3-4 trials per phase. Feasibility and implementation were initiated in the Genitourinary CN, subsequently then integrated into Thoracic Head and Neck, Lymphoma, and Sarcoma CNs. A targeted standardized curriculum was developed for protocol-specific IP requirements, including pre- and post-administration procedures. This model leverages established patient-nurse relationships, enables consistent care within the same physical unit, and enhances continuity and integration of research into clinical practice. Results: This initiative fostered interdisciplinary collaboration between research and clinical practice, enhancing coordination from re-search teams with infusion nurses. Forty trials were implemented across units, significantly increasing CTU capacity for more complex trials. Broader nurse engagement in IP administration enhanced clinical research practice expanding their scope and knowledge. Patients expressed appreciation for continuity of care within their established CN. Infusion nurses reported increased job satisfaction and professional growth through the acquisition of new research skills into their scope of practice. Discussion: On going analysis will be essential to expand the program breadth of IP administration. A dedicated committee has been established to oversee research activities, streamline processes, and foster collabo-ration assuring sustainability and relevant clinical practice across our ambulatory CCC. Strengthening this alliance is essential to promote inquiry improving patient outcomes through innovative oncology care delivery.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N